Reports of Large Immunosuppression Trials in Kidney Transplantation: Room for Improvement

American Journal of Transplantation

Volumn 4, Issue 5, 2004, Pages 738-743

  Fritsche, Lutz ^a   Einecke, Gunilla ^a   Fleiner, Franca ^a   Dragun, Duska ^a   Neumayer, Hans Hellmut ^a   Budde, Klemens ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Clinical trials; Immunosuppression; Kidney transplantation; Reporting quality

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; FOLLOW UP; HISTOCOMPATIBILITY; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RATING SCALE; REVIEW; SYSTEMATIC REVIEW;

CLINICAL TRIALS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION;

EID: 2442596296     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00431.x     Document Type: Article

References (29)

1. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134: 657-662.
2. Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995; 16: 62-73.
3. [wwwdocument]. URL http://www.consort-statement.org, 2003.
4. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
5. Bhandari M, Richards RR, Sprague S, Schemitsch EH. Quality in the reporting of randomized trials in surgery: is the Jadad scale reliable? Control Clin Trials 2001; 22: 687-688.
6. Oremus M, Wolfson C, Perrault A, Demers L, Momoli F, Moride Y. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord 2001; 12: 232-236.
7. Clark HD, Wells GA, Huet C et al. Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials 1999; 20: 448-452.
8. Nunnally JC. Introduction to Psychological Measurement. New York: McGraw-Hill, 1970.
9. Streiner DL, Norman GR. Health Measurement Scales. Oxford: University Press, 1995.
10. Cronbach LG. Coefficient alpha and the Internal Structure of Tests. Psychometrica 1951; 16: 297-334.
11. Nunnally JC. Psychometric Theory. New York: McGraw-Hill, 1978.
12. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
13. Gardner MJ, Altman DG. Statistics with Confidence: Confidence Intervals and Statistical Guidelines. London: BMJ Publishing, 1989.
14. Rothman KJ, Yankauer A. Confidence intervals vs. significance tests. Am J Public Health 1986; 76: 587-588.
15. Bulpitt CJ. Confidence intervals. Lancet 1987; 1: 494-497.
16. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1994; 271: 59-63.
17. Hariharan S, McBride MA, Cohen EP. Evolution of endpoints for renal transplant outcome. Am J Transplant 2003; 3: 933-941.
18. Kasiske BL. Endpoint or turning point? Am J Transplant 2003; 3: 1463-1464.
19. Jadad AR, Boyle M, Cunningham C, Kim M, Schachar R. Treatment of attention-deficit/hyperactivity disorder. Evid Rep Technol Assess (Summ) 1999; 11: i-341.
20. Thornley B, Adams C. Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 1998; 317: 1181-1184.
21. Hotopf M, Lewis G, Normand C. Putting trials on trial - the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health 1997; 51: 354-358.
22. Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I. Size and quality of randomised controlled trials in head injury: review of published studies. BMJ 2000; 320: 1308-1311.
23. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-412.
24. Moher D, Pham B, Jones A et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-613.
25. Hull RD, Raskob GE, Pineo GF et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 1992; 326: 975-982.
26. Cranney A, Waldegger L, Zytaruk N et al. Risedronate for the prevention and treatment of postmenopausal osteoporosis. Cochrane Database Syst Rev 2003; 4: CD004523.
27. Taramarcaz P, Gibson P. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database Syst Rev 2003; 4: CD003570.
28. Boutron I, Tubach F, Giraudeau B, Ravaud P. Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis. JAMA 2003; 290: 1062-1070.
29. Linde K, Jonas WB, Melchart D, Willich S. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol 2001; 30: 526-531.